ImmunityBio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ImmunityBio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • ImmunityBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $34.9M, a 2.41% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $34.9M -$864K -2.41% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $33.8M -$8.74M -20.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $35.2M -$8.99M -20.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $36.5M -$9.25M -20.2% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $35.8M -$10.6M -22.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $42.6M -$5.55M -11.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $44.2M +$8.29M +23.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $45.8M +$9.48M +26.1% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $46.4M +$12.3M +36.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $48.1M +$19.9M +70.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $35.9M +$17.5M +94.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $36.3M +$18.2M +100% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $34.1M +$19.5M +134% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $28.2M +$17.8M +171% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $18.4M +$7.39M +66.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $18.1M -$1.99M -9.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $14.6M +$2.2M +17.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $10.4M -$2.11M -16.8% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $11.1M -$2.1M -16% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $20.1M +$20.1M Dec 31, 2019 8-K/A 2021-04-22
Q3 2019 $12.4M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $12.5M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $13.2M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.